PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Barbiturates”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 721 records · Page 40Linked to original sources

[On the protective effect of barbiturates on the brain during cardiac arrest (author's transl)].

In a suicide attempt a fifty year old woman took 100-200 tablets of barbiturates and benzodiazepines. Subsequently cardiac arrest occurred. Although the prognosis seemed infaust, full clinical recovery took place within a short time. The protection by barbiturates seems to be based on an inhibitory effect on cerebral oxidative enzymes. The maintenance of ventilation and blood pressure as well as the avoidance of pulmonary complications is crucial.

Barbiturates↗

The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in the children of epileptic parents.

A total of 194 children of epileptic mothers and 71 children of epileptic fathers were examined for mental retardation, neurologic disturbances, major malformations, and acrofacial dysmorphias typical for hydantoin-barbiturate embryopathy (HB-E). HB-E was observed in nearly 7% of the children of mothers on anticonvulsants during pregnancy. Barbiturates and/or primidone were observed to induce the same dysmorphic features as hydantoins. The teratogenic potential of hydantoins may be slightly increased in combination with barbiturates/primidone. Neither the 71 children of epileptic fathers nor the 46 children of epileptic mothers without anticonvulsants exhibited symptoms of HB-E. The frequency of major, unspecific malformations was increased in children of epileptic mothers as well as in children of epileptic fathers as compared with the general population. Cerebral disturbances without dysmorphias were increased in children of mothers with and without anticonvulsants, but this was rarely the case in children of epileptic fathers. Cerebral disturbances were observed more often in children of mothers with seizures during pregnancy than in children of mothers without seizures. Multifactorial genetic influences on major malformations and influences of maternal seizures on cerebral disturbances in the offspring are likely.

Abnormalities, Drug-Induced↗

Two new non-barbiturate buffers for electrophoresis of serum proteins on cellulose acetate membranes.

Two new non-barbiturate buffers have been formulated for serum protein electrophoresis on cellulose acetate membranes. Both buffers give five distrinct fractions and are suitable for all systems, but have been primarily designed to meet the needs of the Gelman "Sepratek" system. One buffer is a tris(hydroxymethyl)aminomethane (Tris)/hippurate formulation; the other is composed of Tris/N-[tris(hydroxymethyl)methyl]glycine (Tricine)/sodium chloride/sodium salicylate. Both buffers allow reliable quantitation of protein fractions, giving results that correlated well with those obtained from barbiturate separations. The major advantage of these buffers is that they do not contain drugs of abuse.

Barbiturates↗

High-dose barbiturates for intracranial pressure control.

Approximately 10% of severely head-injured patients will manifest elevated intracranial pressure uncontrollable by any currently known medical or surgical treatments, with a resulting mortality of > 90%. High-dose barbiturate therapy used in this setting has been shown to control intracranial pressure and reduce mortality in a small but definite number of patients. The pharmacologic, physiologic, and systemic effects of high-dose barbiturates must be fully appreciated, and appropriate clinical safeguards must be established when this therapy is implemented after severe head injury.

Barbiturates↗

[The results of forensic chemical research in poisoning by barbituric acid derivatives].

Presents the results of forensic chemical analysis of organs from corpses of subjects dead from barbiturate poisoning at the site of death and at specialized hospitals during rendering specialized medical care. Results of animal experiments are presented. The possibility of detecting long-acting barbiturates (e.g., phenobarbital) 7 to 9 days after the beginning of detoxifying therapy has been demonstrated. A reliable reduction of phenobarbital concentration with prolongation of life after poisoning is detected only in investigation of experimental animal organs.

Acute Disease↗

Application of micellar electrokinetic capillary chromatography to forensic analysis of barbiturates in biological fluids.

Micellar electrokinetic capillary chromatography (MECC) is a form of capillary zone electrophoresis. Addition of a surfactant produces micelles in an aqueous/organic buffer. Separation of drugs is obtained via differences in the electrophoretic mobilities of the analytes within the capillary, resulting from their electrophoretic velocity and the electroosmotic flow of the buffer in a given electric field. The migration order is determined by the differential partitioning of the drugs between the micelles and the aqueous/organic phase. Barbiturates were extracted from various biological fluids at pH 4.5 with TOXI-TUBES B. MECC analyses were performed using a Waters Quanta 4000 Capillary Electrophoretic System with a 745 Data Module with a 75 microns x 60 cm capillary and an aqueous/organic buffer of 85% 10 mM borate, 10 mM phosphate, 100 mM sodium dodecyl sulfate and 15% acetonitrile at a pH of 8.5 with a voltage of 20 kV using ultraviolet absorption detection at 214 nm. Migration times were: phenobarbital, 7.78 min.; butalbital, 8.01 min.; butabarbital, 8.23 min.; mephobarbital (internal standard), 8.88 min.; amobarbital, 9.41 min.; pentobarbital, 10.03 min. and secobarbital, 10.79 min. Correlation coefficients (r) between peak areas and concentration ranges of 3 to 60 micrograms/mL were from 0.964 to 0.999. Coefficients of variation (CV) ranged from 2.6 to 8.6% between days and 2.3 to 9.8% within day. Application of this methodology to four forensic cases of butalbital intoxication detected concentrations of 0.7 to 12.7 micrograms/mL in blood; 0.8 to 1.9 micrograms/mL in vitreous humor and 1.5 to 7.6 micrograms/mL in urine. MECC is applicable to forensic analysis of barbiturates extracted from biological fluids.

Barbiturates↗

[Rapid identification and quantitation of barbiturates in plasma using solid-phase extraction combined with GC-FID and GC-MS method].

A rapid screening method for the quantitation and identification of 7 barbiturates in plasma is presented. The method employs solid-phase extraction at pH 3 using X-5 resin as absorbent. Identification of each barbiturate is achieved by retention time and GC-MS. Detection threshold (0.3-0.5 micrograms.ml-1 in a 0.5 ml plasma sample and 1 microliter injection volume), precision (RSD 3.46-6.41%), and linearity (r > 0.99) were satisfactory for blood level monitoring and clinical toxicological applications.

Barbiturates↗

Barbiturate therapy for status epilepticus in the postanesthesia care unit.

Although rare, status epilepticus refractory to conventional therapy may require the initiation of pentobarbital anesthesia and intensive monitoring in the PACU. Barbiturate therapy mandates that the nurse be able to perform mechanical ventilation and advanced cardiopulmonary monitoring as well as be familiar with electroencephalographic monitoring. Careful attention to the potential side effects of barbiturate therapy and anticipation of end-organ complications can increase the likelihood of seizure termination and recovery of status epilepticus patients.

Barbiturates↗

Do barbiturates and their solutions suppress FMLP-induced neutrophil chemiluminescence?

The dose-response relationship of four commercially available barbiturates (methohexitone, pentobarbitone, phenobarbitone and thiopentone) and of their drug-free solutions on the production of oxygen radicals by neutrophils were tested by N-formylmethionyl-leucyl-phenylalanine (FMLP)-induced granulocyte chemiluminescence and in a cell-free chemiluminescence system. Methohexitone had no effect on neutrophil chemiluminescence. Pentobarbitone, phenobarbitone and thiopentone dose-dependently decreased FMLP-induced chemiluminescence and cell-free chemiluminescence. Suppression of neutrophil chemiluminescence by pentobarbitone and phenobarbitone was due to effects of the drug-free solutions and an osmolality greater than 360 mosmol kg-1. Only thiopentone suppressed granulocyte chemiluminescence drug-specifically. The physicochemical properties of commercially available barbiturate preparations and their solutions, as well as free radical scavenging capacity, have to be considered if these preparations are used to evaluate drug-specific effects on the production of oxygen radicals by neutrophils.

Barbiturates↗

[Solid-phase immunoenzyme method of quantitative determination of barbiturates].

A solid-phase competitive enzyme immunoassay for measurements of barbiturates in biologic tissues of human body was developed. Antibodies to barbiturate derivatives, obtained by rabbit immunization with conjugated antigen (barbamyl conjugate with ovalbumin) were used as reagents in the assay. Together with the chromatographic procedures the developed EIA may be used in practical forensic medicine and narcology.

Animals↗

A calcium reversible action of barbiturates on the leech Retzius cell.

The Na salts of phenobarbital, barbital, pentobarbital, secobarbital, methohexital and thiopental in concentrations of 1 to 5 mM all caused prolonged action potentials in leech Retzius cells. The prolongation was favored by low Ca and was reversible by elevation of Ca. Barbiturate-prolonged action potentials were not affected by 50 micronm tetrodotoxin or replacement of Cl by propionate, but they were dependent on external Na. Their amplitudes were increased by steady hyperpolarization and input resistance was reduced during them. They were of shorter duration when elicited at a rapid rate. They were sometimes shortened by intracellular iontophoresis of Ca and by use of the ionophore X537A, but technical factors complicated the interpretation of both kinds of experiments. The results are consistent with the hypothesis that the barbiturates used blocked a voltage-dependent inward Ca current which activates a K conductance necessary for normal repolarization.

Action Potentials↗

What is barbiturate dependence and who is at risk?

The dependence on drugs today, particularly by young people, must concern many - doctors and nurses, social workers, lawyers and the police, and parents. The writers of the group of papers which follow, although inevitably overlapping in some respects, attempt to examine the questions raised from the particular point of view of each. When does taking a drug (generally a barbiturate) become a state of dependence is the question posed and answered by Dr Connell. He begins by setting out the series of offical definitions of addiction, habituation and dependence formulated by the World Health Organization and in Britain by the Interdepartmental Committee (the Brain Committee). With these definitions as a framework he examines barbiturate dependence and abuse in the setting of current medical practice.

Adolescent↗

The moral choice in prescribing barbiturates.

Dr Wells, a general practitioner, looks at the problem of barbiturate dependence from the point of view of the prescribing doctor who has to choose for his patients - of all ages - the drug, usually a hypnotic, which is sought for insomnia or states of anxiety and stress. He argues that it is wise to prescribe non-barbiturates, but that even in elderly people it is possible and the right course of action is to wean these patients from their dependence on sleep-inducing drugs. Young people often acquire the drug habit by taking hypnotics from a bedside table or a bathroom cabinet in their own homes.

Barbiturates↗

No barbiturate protection in a dog model of complete cerebral ischemia.

Complete global ischemia was produced in 39 dogs by temporary ligation of the aorta. Prior to the ischemic episode, pentobarbital (30 to 45 mg per kilogram of body weight) was administered to 19 of these dogs. The neurological effects of cerebral ischemia episodes lasting 8, 9, or 10 minutes were compared in dogs treated with pentobarbital and those not treated. At 48 hours following the ischemic episode most of the dogs made ischemic for 8 minutes were normal, whereas most animals made ischemic for 10 minutes were dead or comatose. The 9-minute ischemic period resulted in a relatively even distribution of normal and damaged dogs. There were no differences between treated and untreated dogs. Cerebral blood flow, cerebral metabolic rate for oxygen, and various cerebral metabolites were measured in dogs surviving 48 hours. Again, there were no differences between treated and undertreated dogs. We conclude that barbiturates provide no protection in this model of complete global ischemia. This conclusion supports the hypothesis that the likely mechanism of barbiturate protection in models of incomplete ischemia or hypoxia is based on cerebral metabolic depression; such a mechanism would not be expected to be effective in complete global ischemia.

Animals↗

Habituation of the head-poke response: effects of an amphetamine-barbiturate mixture, PLG and fenfluramine.

A test situation was developed in which the effects of drugs on habituation of exploratory behavior (head-poke responses) could be assessed independently of their effects on general activity (locomotion and rearing). Habituation, spontaneous recovery from habituation and stimulus specificity of habituation were studied. An amphetamine-barbiturate mixture attenuated habituation of the head-poke response without influencing general activity. Pro-Leu-Gly-NH2 (PLG), an oxytocin fragment, increased locomotor activity and did not alter the course of habituation of the head-poke response. Since exploratory behavior and general activity can be pharmacologically dissociated in the test situation used, it is concluded that the test situation is suitable for studying the effects of drugs on habituation of exploratory behavior. The amphetamine-barbiturate mixture did not influence the stimulus specificity of habituation of the head-poke response. Fenfluramine however increased the effects of stimulus change on the head-poke response while not influencing habituation of this response. These results show that habituation and stimulus specificity of habituation of exploratory behavior can be pharmacologically dissociated.

Amobarbital↗

Reduction of barbiturate anaesthesia by new glutarimide compounds in mice.

Newly synthesized glutarimide compounds (Table 1) at doses of 4, 8 and 16 mg/kg (IP) reduced the duration of sleep induced by pentobarbitone in mice. Compounds 1 to 7 and 21 were more potent than the other compounds and their activity was comparable to the reference drug, bemegride. The structure activity relationship for the decrease in duration of barbiturate anaesthesia caused by the various groups of these compounds was mainly found to be inversely related to the length of the alkyl side chain at position 4 of the beta carbon atom. It was also shown that the presence of piperidine, diethylamine and morpholine moieties attached to 3,5-dicyanoglutarimide was partly responsible for the reduction in barbiturate anaesthesia by these compounds.

Animals↗

Effect of isolation on barbiturate anaesthesia in the rat.

The duration of barbiturate-induced sleeping in rats was found to be reduced by isolation housing. It was also lower in males than females, and lower in the dark phase of the diurnal cycle. These variables were shown to be additive in their effects. Sex differences in barbiturate action were found to be reduced by gonadectomy in males; and the effects of isolation were found to depend upon housing conditions at the time of testing rather than upon early rearing environment. The implication for theories of arousal is discussed.

Anesthesia↗

Clinical outcome and cognitive impairment in patients with severe head injuries treated with barbiturate coma.

This study reports on clinical outcome in 38 patients with severe head injuries (posttraumatic coma for 6 hours or more) treated with barbiturate coma because of intracranial hypertension. Eighteen patients died, 4 patients remained in a severely disabled or a chronic vegetative state, and 16 patients reached the levels good recovery/moderate disability. Six of these patients returned to work or school full time, 4 for half time and 3 were in a rehabilitation program. Fourteen patients were subjected to a comprehensive neuropsychological assessment. All patients except one exhibited varying degrees of cognitive dysfunction and 6 patients had signs of personality change. The quality of life for the majority of surviving patients was relatively good but the positive effects of barbiturate coma therapy in the age groups over 40 years appeared to be limited.

Adult↗